carbachol has been researched along with Adverse Drug Event in 3 studies
Carbachol: A slowly hydrolyzed CHOLINERGIC AGONIST that acts at both MUSCARINIC RECEPTORS and NICOTINIC RECEPTORS.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Liu, Z | 1 |
Shi, Q | 1 |
Ding, D | 1 |
Kelly, R | 1 |
Fang, H | 1 |
Tong, W | 1 |
Uno, T | 1 |
Kobayashi, F | 1 |
Ogata, A | 1 |
Konomi, T | 1 |
Drance, SM | 1 |
1 review available for carbachol and Adverse Drug Event
Article | Year |
---|---|
[Pharmacological and clinical profile of imidafenacin developed as a new therapeutic agent for overactive bladder].
Topics: Acetylcholine; Animals; Carbachol; Clinical Trials as Topic; Drug-Related Side Effects and Adverse R | 2008 |
2 other studies available for carbachol and Adverse Drug Event
Article | Year |
---|---|
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Da | 2011 |
Medical management of glaucoma.
Topics: Acute Disease; Carbachol; Carbonic Anhydrase Inhibitors; Child; Cholinesterase Inhibitors; Chronic D | 1967 |